Cancers belong to a group of debilitating diseases of humans. Breast cancer is the most frequently diagnosed cancers and the leading cause of cancer deaths among women worldwide.
In the United States of America, it is the second most diagnosed cancers after skin cancer. Bear in mind that breast cancer can affect both male and female, although more frequent in females.
Self-breast examination remains one of the most viable means of early detecting the presence of a lump in the breast, changes in the size and shape of a breast or changes in the appearance of the breast – all of which could be a pointer to an underlying breast cancer.
So, women are advised to familiarise themselves with their breasts so they can detect in time any change(s).
Similarly, one of the ways to control the morbidity and mortality associated with breast cancer is to go for screening tests. There are quite a number of options available to women in developed countries.
However, access to such facilities in developing countries, albeit available, are still limited. Relatedly, this access limitation varies from one country to another.
One of such screening tests is mammography. Mammography, although does not in itself prevent cancers but can help in its early detection.
Nevertheless, this means of early detection is now a source of worry according to a recent study.
Findings from the study show that when mammography screening tests turnout to be false positives, then the chances of screen-detected and interval breast cancers are higher in the long term.
The study findings were published on December 19 in the British Journal of Cancer.
Marta Román, Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain ; Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain